Zhejiang Cancer Hospital: Esophageal Neoplasms trials

The registry lists 11 Esophageal Neoplasms studies with Zhejiang Cancer Hospital as lead sponsor. 1 are open to participants now and 0 have results posted.

Early Phase 1 1Phase 1 2Phase 2 4Phase 3 3No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Multicenter, Randomized Controlled, Phase II Clinical Study of First-line Chemotherapy and Camrelizumab With or Without Radiotherapy in the Treatment of Oligometastatic Esophageal CancerNot yet recruitingNCT05183958Phase 2
• A Clinical Study Of Camrelizumab With Or Without Radiotherapy In The Treatment Of Esophageal CancerStatus unknownNCT04512417Phase 2
• A Study of Sintilimab Plus Chemoradiation Before Surgery for Esophageal CancerStatus unknownNCT03940001Early Phase 1
• Different Radiation Dose of Neoadjuvant Chemoradiation for Resectable Thoracic Esophageal Squamous CarcinomaCompletedNCT03381651Not applicable
• S-1 Concurrent With Radiotherapy Versus Radiotherapy for Elderly Patients With Esophageal CancerCompletedNCT02813967Phase 3
• A Phase III Trail of Adjuvant Chemoradiotherapy Versus Adjuvant Radiotherapy in Esophageal Squamous Cell CarcinomaStatus unknownNCT02570893Phase 3
• Comparable Study of Different Radiation Dose in Esophageal CarcinomaStatus unknownNCT01937208Phase 3
• Neoadjuvant Versus Adjuvant Therapy in Treating Resectable Thoracic Esophageal CancerStatus unknownNCT01463501Phase 2
• Gefitinib Combined With Radiotherapy in Elderly Patients With Esophageal CancerStatus unknownNCT01291823Phase 2
• S-1 Plus Nedaplatin With Concurrent Radiotherapy for Advanced Esophageal CancerCompletedNCT01175460Phase 1
• S-1 and Radiotherapy in Elderly Patients With Esophageal CancerCompletedNCT01175447Phase 1